市場調查報告書
商品編碼
925263

血肌酐化驗套件市場 - 成長,趨勢,預測(2020年∼2025年)

Creatinine Assay Kits Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球血肌酐化驗套件市場在2020年∼2025年間,預測將以5.3%的年複合成長率擴大。由於腎障礙以及其他慢性障礙的發生率增加,腎障礙相關的生物醫學調查的技術性進步,及調查開發的配合措施增加等,也提高血肌酐化驗套件的需求。

本報告提供血肌酐化驗套件的世界市場調查,市場概要,各類型,各地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊 。

目錄

第1章 簡介

  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各類型
    • Jaffe動力學測試套件
    • 血肌酐-PAP試驗套件
    • ELISA試驗套件
  • 各樣品類型
    • 血液/血清
    • 尿
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Abbott Laboratories
    • Thermo Fisher Scientific
    • Merck KGaA
    • Quidel Corporation
    • Cell Biolabs, Inc
    • Genway Biotech
    • Randox Laboratories Ltd
    • ACON Laboratories
    • Nova Biomedical
    • Sysmex India Pvt. Ltd

第7章 市場機會及未來趨勢

目錄
Product Code: 67729

The Creatinine Assay Kits Market is expected to register a CAGR of 5.3% during the forecast period. Creatinine assay kits are used to measure creatinine levels in serum/plasma, urine and other biological samples. Creatinine is a waste product produced by muscles from the breakdown of creatine compound and removed from the body by the kidneys, which filter from the blood and release it into the urine. Creatinine assay is used to analyze the protein metabolism in the body and the levels of creatinine can be affected by changes in muscle mass, pregnancy, cancer, etc. Creatinine levels in the blood will increase and will deflect in the blood test if the kidney is not in the good condition. Creatinine test is performed by using specific creatinine assay kit and can be performed for different conditions like hypertension, diabetes and cancers. According to International Society of Nephrology, every year approximately 13.3 million cases of acute kidney injury (AKI) globally, particularly high in emerging countries, where annual incidence is estimated to be 11.3 million. Increasing incidence of renal disorders and other chronic disorders, technological advancements in biomedical research pertaining to kidney disorders and increasing research and development initiatives are the key driving factors in creatinine assay kits market.

Key Market Trends

Jaffe's Kinetic Test Kits Segment is Expected to Hold a Major Market Share in the Creatinine Assay Kits Market

  • Jaffe reaction is a colorimetric method used in clinical chemistry to measure creatinine levels in blood and urine using Jaffe's Kinetic Test Kits.
  • According to the National Kidney Foundation, about 10% of the population worldwide is affected by chronic kidney disease (CKD), and millions die each year with kidney disease.
  • Jaffe's Kinetic Test Kits segment hold a significant market share in the creatinine assay kits market and is anticipated to show a similar trend over the forecast period due to being the conventional method for creatinine measurement and the wide product availability, as well as the cost-effectiveness of these kits.
  • Increasing incidence of renal disorders and other chronic disorders impacting renal function, technological advancements in biomedical research pertaining to kidney disorders are the key driving factors in the Jaffe's kinetic test kits segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global creatinine assay kits market due to increasing incidence of renal disorders and other chronic disorders impacting renal function and technological advancements in biomedical research pertaining to kidney disorders in this region. According to the Centers for Disease Control and Prevention (CDC), approximately 30 million people or 15% of United States adults are estimated to have chronic kidney disease (CKD). chronic kidney disease (CKD) is estimated to be more common in women (16%) than in men (13%). Furthermore, favourable reimbursement policies and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Creatinine Assay Kits Market is highly fragmented competitive and consists of several major players. In terms of market share, majority of the players are currently dominating the market. Some of the companies which are currently dominating the market are Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Quidel Corporation, Cell Biolabs, Inc, Genway Biotech, Randox Laboratories Ltd, ACON Laboratories, Nova Biomedical and Sysmex India Pvt. Ltd.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Renal and Other Chronic Disorders Impacting Renal Function
    • 4.2.2 Technological Advancements in Biomedical Research Pertaining to Kidney Disorders
    • 4.2.3 Increasing Research and Development Initiatives
  • 4.3 Market Restraints
    • 4.3.1 Identification of Novel Renal Dysfunction Biomarkers
    • 4.3.2 Limited Usage of Creatinine Assay Kits in Invitro Diagnostic Device (IVD)
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Jaffe's Kinetic Test kits
    • 5.1.2 Creatinine-PAP Test kits
    • 5.1.3 ELISA Test kits
  • 5.2 By Type of Sample
    • 5.2.1 Blood/Serum
    • 5.2.2 Urine
    • 5.2.3 Other Samples
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Merck KGaA
    • 6.1.4 Quidel Corporation
    • 6.1.5 Cell Biolabs, Inc
    • 6.1.6 Genway Biotech
    • 6.1.7 Randox Laboratories Ltd
    • 6.1.8 ACON Laboratories
    • 6.1.9 Nova Biomedical
    • 6.1.10 Sysmex India Pvt. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS